J&J SNACK FOODS CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data J&J SNACK FOODS CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	993	1,084	1,138	1,186	1,022	1,145	1,381	1,559	1,575	1,583
Cost of revenue	688	753	802	836	784	846	1,011	1,089	1,089	1,113
Gross profit	304	331	336	350	238	299	370	470	486	470
Research and development	0.53	0.67	0.62	0.65	0.7	0.6	0.7	1.2	1.2	1.4
Selling and marketing	86	94.4	95.4	96.4	85	77.9	91.6	110	119	124
General and administrative	32.3	36.8	37.8	40.7	36.7	40.5	55.2	75.4	74.8	77.8
Operating expenses	192	213	226	233	221	228	308	360	369	386
Operating income	113	118	111	117	17.2	71.2	61.8	110	118	84.3
Interest expense	0.12							4.75	1.83	1.49
Other non-operating income		0.15	-0.07	-1.41
Pre-tax income	117	122	118	127	21.5	74	61.8	108	119	86.4
Income tax	40.8	43	14.6	31.8	3.16	18.4	14.5	28.6	32.4	20.8
Net income	76	79.2	104	94.8	18.3	55.6	47.2	78.9	86.6	65.6
EBITDA	153	161	157	166	70.2	121	115	173	188	158
EPS, basic	4.07	4.23	5.54	5.04	0.97	2.92	2.47	4.10	4.46	3.37
EPS, diluted	4.05	4.21	5.51	5.00	0.96	2.91	2.46	4.08	4.45	3.36
Shares, basic (weighted)	18.6	18.7	18.7	18.8	18.9	19	19.1	19.3	19.4	19.5
Shares, diluted (weighted)	18.8	18.8	18.8	19	19	19.1	19.2	19.3	19.4	19.5
Dividend per share								0.74	0.78	0.80

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	141	91	111	192	196	283	35.2	49.6	73.4	106
Receivables	98.3	125	132	141	127	163	208	198	189	184
Inventory	88.7	103	113	116	109	123	180	172	173	175
Other current assets	13.9	3.94	5.04	5.77	17.1	7.5	16.8	11	14.6	13.2
Total current assets	355	382	383	506	500	585	445	430	450	478
Property, plant and equipment	184	228	243	253	262	267	335	386	391	390
Lease right-of-use assets				0	58.1	54.6	51.1	88.9	152	152
Goodwill	86.4	103	103	103	122	122	184	185	185	185
Long-term investments					14	10.1	5.71	0
Other non-current assets	2.71	2.86	2.76	2.84	2.91	1.97	3.97	3.65	3.79	3.76
Total assets	790	867	938	1,019	1,057	1,122	1,217	1,277	1,365	1,382
Accounts payable	62	72.7	69.6	72	73.1	96.8	108	90.8	89.3	82.4
Accrued liabilities	6.16	7.75	8.03	7.81	7.42	11	9.21	14.2	10.1	12.6
Short-term debt	13.6									0
Total current liabilities	102	119	118	121	134	168	182	175	174	176
Long-term debt						0	55	27	0	0
Lease liabilities				0	47.7	46.6	42.7	77.6	141	140
Other non-current liabilities	0.8	2.25	1.95	1.72	0.46	0.41	3.64	4.23	5.04	6.06
Total liabilities	153	185	173	186	247	277	354	366	408	415
Total debt	13.6					0	55	27	0	0
Retained earnings	626	674	744	801	776	785	783	807	836	840
Other comprehensive income	-13.4	-8.88	-12	-13	-15.6	-13.4	-13.7	-10.2	-15.3	-12.6
Shareholders' equity	638	682	759	834	809	846	863	912	957	967
Total equity	638	682	759	834	809	846	863	912	957	967
Total liabilities and equity	790	867	932	1,019	1,057	1,122	1,217	1,277	1,365	1,382
Shares outstanding	18.7	18.7	18.8	18.9	18.9	19.2	19.2	19.3	19.4	19.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	76	79.2	104	94.8	18.3	55.6	47.2	78.9	86.6	65.6
Depreciation and amortization	40.1	42.4	46.5	48.6	53	49.4	53.1	63.1	70.6	73.3
Stock-based compensation	2.38	3.05	3.86	4.23	4.6	4.2	4.27	5.32	6.22	6.32
Deferred income tax	7.66	7.89	-10.4	9.6	2.49	-2.84	8.83	11.7	6.43	2.69
Change in receivables	3.57	-20.4	-7.92	-8.76	14.6	-35.8	-32.8	11.4	7.93	5.5
Change in inventory	-6.3	-7.41	-9.64	-3.23	7.88	-14.2	-49.4	9.48	-1.01	-2.32
Change in payables	3.89	9.52	-1.74	2.15	-4.78	35.4	2.71	-14.4	-0.49
Cash from operations	121	125	123	147	92.1	101	26.1	172	173	165
Capital expenditures	-48.7	-72.2	-60	-57.1	-57.8	-53.6	-87.3	-105	-73.6	-82.9
Acquisitions		-47.7	0	-1.16	-57.2	0	-221	0	-7.01	0
Purchases of investments	-41.8	-39.9	-91.1	-26.1	-6.1	0	0
Sales and maturities of investments	13.2	23	75.3	39.2	73.2	60.9	12	9.72	0	0
Cash from investing	-74.6	-135	-73.1	-43.4	-44.5	9.94	-296	-93.2	-77.7	-70.1
Stock issued	6.57	7.23	8.89	14.2	7.9	20.3	16.2	15.2	15.7	4.28
Share buybacks	-15.3	-18.2	-2.79	0	-8.97	0	0	0	0	-8
Dividends paid	-28.5	-30.9	-33.1	-36.6	-42.1	-44.8	-48.4	-53.9	-57	-60.8
Cash from financing	-37.6	-42.2	-27.3	-22.8	-43.5	-24.7	22.2	-66.8	-68.4	-64.7
Exchange rate effect	-2.09	2.49	-2.38	-0.39	-0.8	0.62
Net change in cash	6.96	-49.7	20.5	80.9	3.41	87.4	-248	14.4	23.8	32.5
Free cash flow	72.5	53.2	63.3	90.4	34.3	47.9	-61.2	67.5	99.5	82.3
Interest paid	0.06	0.05	0.04	0.04	0.03	0.03	0.95	4.75	1.79	1.5
Income taxes paid	41.1	25	25.8	23	11.6	11.6	16.8	8.62	26.9	18

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $77.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.3%	Gross profit / revenue.
Operating margin	3.9%	Operating income / revenue.
EBITDA margin	8.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.0%	Pre-tax income / revenue.
Net margin	3.2%	Net income / revenue.
FCF margin	6.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.9%	Cash from operations / revenue.
Effective tax rate	19.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.6%	Net income / average total assets.
Return on invested capital (ROIC)	5.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.9%	Capital expenditures / revenue.
D&A / revenue	5.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	14.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-28.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	10.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	37.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-16.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	11.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-24.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	11.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	29.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-24.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	11.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	28.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	85.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	12.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-17.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	19.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	2.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	1.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.34x	Current assets / current liabilities.
Quick ratio	1.39x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.32x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.03x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	2.1%	Total debt / total assets.
Liabilities / assets	34.2%	Total liabilities / total assets.
Net debt	-$35.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.26x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	27.8x	Operating income / interest expense.
Working capital	$264.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$707.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.12x	Revenue / average total assets.
Fixed asset turnover	3.97x	Revenue / average property, plant and equipment.
Inventory turnover	6.12x	Cost of revenue / average inventory.
Days inventory	60 days	365 x average inventory / cost of revenue.
Receivables turnover	7.24x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
Days payables	34 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	76 days	Days inventory + days sales outstanding - days payables.
FCF conversion	186.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	44.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.63	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$81.34	Revenue / diluted weighted shares.
FCF per share	$4.91	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.90	Cash from operations / diluted weighted shares.
Book value per share	$47.89	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$37.95	Tangible book value / shares outstanding.
Cash per share	$3.39	(Cash + short-term investments) / shares outstanding.
Payout ratio	123.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	66.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	84.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.45B	Share price x shares outstanding.
Enterprise value	$1.41B	Market cap + total debt - cash - short-term investments.
P/E	29.4x	Market cap / net income. Only when net income is positive.
P/S	0.95x	Market cap / revenue.
P/B	1.62x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.05x	Market cap / tangible book value, when positive.
P/FCF	15.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.68x	Market cap / cash from operations, when positive.
EV/Sales	0.93x	Enterprise value / revenue.
EV/EBIT	23.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.4x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.4%	Free cash flow / market cap.
Earnings yield	3.4%	Net income / market cap (the inverse of P/E).
Dividend yield	4.2%	Dividends paid over the period / market cap.
Shareholder yield	9.6%	(Dividends paid + share buybacks) / market cap.
PEG	2.68x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was J&J SNACK FOODS CORP's revenue in fiscal 2025?

J&J SNACK FOODS CORP reported revenue of $1.58B for fiscal 2025, 0.5% higher than the year before.

Was J&J SNACK FOODS CORP profitable in fiscal 2025?

Yes. Net income was $65.6M, a net margin of 4.1%.

How much free cash flow did J&J SNACK FOODS CORP generate in fiscal 2025?

Cash from operations of $165.1M minus capital expenditures of $82.9M left free cash flow of $82.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to J&J SNACK FOODS CORP